💎 Fed’s first rate cut since 2020 set to trigger market. Find undervalued gems with Fair ValueSee Undervalued Stocks

Aflac shares tick up as operating profits surge 15%, despite weak yen

Published 02/01/2016, 06:33 PM
Updated 02/01/2016, 06:38 PM
Aflac topped analysts' expectations with its fourth quarter revenues on Monday
AFL
-

Investing.com -- Shares in Aflac Incorporated (N:AFL) ticked up in after-hours trading after the largest provider of supplemental insurance in the U.S. reported a considerable increase in its operating profit during the fourth quarter.

For Aflac's fourth quarter of fiscal year 2015, which ended in late-December, the company reported earnings of $730 million or 1.71 per share, up from $703 million or 1.57 per share during the same period in 2014. For the three-month period, Aflac's earnings were suppressed by a weaker yen as the Japanese currency traded at an average of 121.54 versus the dollar in the fourth quarter. It represented a decline of nearly 6% in comparison with the dollar-yen exchange rate in the final quarter a year earlier. As a result, the impact of foreign exchange translation contributed to a 0.05 loss per share in quarterly earnings, Aflac said.

Aflac derives a significant portion of its global business from its Japanese segment. Over the last year, the company insured approximately a quarter of all households in Asia's second-largest economy.

“We are very pleased with Aflac’s financial performance for both the quarter and year," Aflac CEO Daniel P. Amos said in a statement. "Aflac had a very strong quarter, and we finished the year above the top of the range for operating earnings per diluted share, excluding the impact of foreign currency."

While Aflac's revenues fell by 3.5% to 5.32 billion on the quarter, the company still topped analysts' forecasts of 5.22 billion for the period. In Japan, Aflac's premium income gained 0.3% in yen terms but fell more than 5.5% to $3.6 billion when measured in dollar-denominated terms. Aflac's revenue and premium income in its U.S. division both increased by more than 2% on the quarter.

Amos also sounded optimistic about the company's third sector sales in 2015, which were driven by a 40% increase in its cancer insurance revenues. For the year as a whole, the company's third sector sales soared by 13.6%, achieving their strong growth rate in more than a decade.

"As we indicated during our December outlook call, we anticipate that for 2016, sales of third sector products will be down mid-single digits following very robust production results in 2015," Amos added. "We continue to believe the long-term compound annual growth rate will be in the range of 4% to 6%."

Shares in Alfac gained 0.86 or 1.52% to 57.38 in after-hours.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.